# UNH — slm-full-gpu

## Metadata

ticker: UNH
arm: slm-full-gpu
judge_prompt_version: v2
context_sha256: 42558046cfccc541ced1475f1e98f804156c225a5eb993c61e1e8079bcc7de40
slm_endpoint: slm-gpu
slm_url: http://132.145.161.150:30880
slm_served_name: qwen3.6-35b-a3b-q4km
slm_artifact: ggml-org/Qwen3.6-35B-A3B-GGUF@baec3ebee244827cda0f4557eafa8b28f7545fa6:Qwen3.6-35B-A3B-Q4_K_M.gguf sha256:671e47e0ec53c665d048b98c3ecbfd5236b5ca9c3e02ed19fc8f81f7b85140c7
slm_build: b11347-5fc4f3c8c
slm_model_path: /models/Qwen3.6-35B-A3B-Q4_K_M.gguf
slm_model_ftype: Q4_K - Medium
slm_total_slots: 4
slm_n_ctx: 32768
slm_n_params: 34660610688
slm_model_size_bytes: 20408576512
slm_thinking: off
slm_sampling: {"planner": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "rag": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 2048, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "react": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "section": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 768, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "synthesis": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 4096, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.2, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}}
llm_calls: 7
llm_endpoints: slm-gpu
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 630, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 12.392, "latency_s_total": 12.392, "parse_failure": 0, "prompt_tokens": 3060, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 455, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 10.635, "latency_s_total": 10.635, "parse_failure": 0, "prompt_tokens": 3049, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 130, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 4.794, "latency_s_total": 4.794, "parse_failure": 0, "prompt_tokens": 861, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 109, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 4.499, "latency_s_total": 4.499, "parse_failure": 0, "prompt_tokens": 855, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 167, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 5.157, "latency_s_total": 5.157, "parse_failure": 0, "prompt_tokens": 526, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 106, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 4.436, "latency_s_total": 4.436, "parse_failure": 0, "prompt_tokens": 709, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 791, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 8.813, "latency_s_total": 8.813, "parse_failure": 0, "prompt_tokens": 1400, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "UNH",
  "company_name": "UnitedHealth Group Incorporated",
  "current_price": 378.58,
  "currency": "USD",
  "market_cap": 339811434496.0,
  "pe_ratio": 24.34598,
  "forward_pe": 16.743778,
  "week_52_high": 461.62,
  "week_52_low": 255.97,
  "financial_currency": "USD",
  "revenue": 450525986816.0,
  "net_income": 14122000384.0,
  "profit_margin_pct": 3.14,
  "dividend_yield": 2.45,
  "sector": "Healthcare",
  "industry": "Healthcare Plans"
}

NEWS ARTICLES:
[
  {
    "title": null,
    "source": null,
    "published_at": null,
    "description": null
  }
]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-03-02",
    "summary": "ITEM 1A. RISK FACTORS CAUTIONARY STATEMENTS The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cshould\u201d or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the \u201csafe harbor\u201d provisions of the PSLRA"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-10",
    "summary": "ITEM 1A. RISK FACTORS In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, \u201cRisk Factors\u201d of our 2025 10-K, which could materially affect our business, financial condition or future results. The risks described in our 2025 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes to the risk factors as disclosed in our 2025 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities (a) Second Quarter 2026 For the Month Ended Total Number of Shares Pu"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] Based on the provided risk factors from the Annual Report on Form 10-K, the key takeaways regarding potential risks to the company’s business, financial position, and operations include:

**1. Medical Cost Management and Pricing Risks**
*   **Profitability Dependence:** The profitability of risk-based products, which constitute nearly 80% of total consolidated revenues, relies heavily on the ability to accurately predict, price, and manage medical and administrative costs.
*   **Estimation Variability:** Benefit expense estimates involve significant judgment and variability. Small differences between predicted and actual medical costs or utilization rates can lead to significant changes in financial results.
*   **Unrecoverable Costs:** Factors such as medical cost inflation, increased service usage, provider billing intensity, pandemics, climate change effects, and new drug costs can cause actual expenses to exceed premiums. These excess costs typically cannot be recovered during the fixed premium period.
*   **Value-Based Care:** For Optum Health’s fully accountable value-based arrangements, failure to deliver higher-quality outcomes at lower costs or to successfully integrate care delivery models could adversely impact financial results.

**2. Cybersecurity and Data Privacy**
*   **Security Incidents:** The company faces ongoing risks from cyberattacks, data breaches, and privacy incidents. A notable example cited is a 2024 cyberattack on the recently acquired Change Healthcare business, which involved protected health information and personally identifiable information.
*   **Sophisticated Threats:** Threat actors are increasingly using sophisticated techniques, including generative AI, to penetrate security controls, deploy ransomware, and disrupt operations. The company may struggle to anticipate these evolving threats or implement adequate preventive measures.
*   **Consequences:** Successful attacks could result in revenue loss, increased costs, regulatory penalties, litigation, reputational harm, and operational disruptions.
*   **Third-Party Risks:** Reliance on third-party vendors for data processing introduces additional vulnerabilities outside of the company’s direct control.

**3. Technology Systems and Data Integrity**
*   **System Integration and Defects:** Failure to protect, consolidate, and integrate information systems, or the presence of design defects in software products, could lead to higher-than-expected costs and material adverse effects on operations.
*   **Data Accuracy:** The business depends on the integrity, timeliness, and accuracy of data. Inaccurate, incomplete, or outdated data could lead to failures in health and IT products, loss of customers, difficulties in fraud prevention, and regulatory sanctions.
*   **AI and Technological Evolution:** The company anticipates that fast-evolving AI technologies, including generative AI, will play a critical role in its systems. Keeping pace with these technological changes, along with regulatory standards and customer preferences, requires significant ongoing resources. Failure to do so could result in reputational harm and adverse business effects.
*   **Regulatory Compliance:** Rapidly evolving laws and regulations regarding health data and AI technologies may alter the competitive landscape and impose new compliance requirements, potentially affecting the configuration of information systems and market competitiveness.

RAG — RISK FACTORS:
[From Pinecone cache] The primary risk factors disclosed include:

*   **Inaccurate Cost Estimation and Management:** Failure to accurately estimate, price, or manage medical costs and benefit designs for risk-based products could materially and adversely affect results of operations, financial position, and cash flows. This is particularly relevant because premium revenues from these products constitute nearly 80% of total consolidated revenues. Actual costs may exceed estimates due to factors such as medical cost inflation, increased service utilization, provider billing intensity, pandemics, climate change effects, new or costly drugs, and regulatory changes.
*   **Data Integrity and Information Systems:** Failure to maintain the integrity, availability, or security of data, or to successfully consolidate, integrate, upgrade, or expand information systems, could materially and adversely affect the business. This includes risks associated with inaccurate data, failures in health or IT products, difficulty in pricing products, fraud detection issues, and regulatory sanctions. Additionally, the rapid expansion of healthcare data and the increasing role of artificial intelligence (AI) require significant ongoing resources to keep pace with technological changes.
*   **Cybersecurity and Data Privacy:** Exposure to cyberattacks, privacy breaches, or data security incidents involving protected personal information or proprietary data could result in revenue loss, increased costs, liability, reputational harm, and operational disruptions. This includes risks from third-party vendors, evolving AI-based threats, and previously reported incidents such as the cyberattack on the Change Healthcare business.
*   **Relationships with Healthcare Providers:** Failure to develop and maintain satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers could materially and adversely affect the business.
*   **Value-Based Care Performance:** For Optum Health’s fully accountable value-based care, an inability to provide higher-quality outcomes and better experiences at lower costs, or to integrate care delivery models, could impact financial results.
*   **Software Defects:** Software products sold and installed by the company may contain unexpected design defects or encounter complications during installation or use, which could adversely affect results of operations.
*   **Regulatory Changes:** Uncertain and rapidly evolving laws and regulations related to health data and health information technologies, including those involving AI, may alter the competitive landscape or impose new compliance requirements.

## Pre-written sections (judge input)

### Financial Health

UnitedHealth Group trades at $378.58 with a market capitalization of approximately $339.8 billion, supported by robust annual revenue of $450.5 billion. The company reports a trailing P/E ratio of 24.35, though the forward P/E of 16.74 suggests anticipated earnings growth. Despite a relatively thin net profit margin of 3.14%, the firm generates substantial net income of $14.1 billion, indicating strong operational scale. This valuation reflects investor confidence in the healthcare giant's ability to maintain profitability amidst sector challenges.

### Recent Developments

UnitedHealth Group has filed its 2026 10-K and 10-Q reports, with the latter confirming no material changes to the risk factors previously disclosed in the 2025 annual filing. The company continues to execute its capital return strategy, as evidenced by ongoing share repurchase activities detailed in the second quarter 2026 equity securities report. Investors should monitor these filings for any emerging regulatory or operational risks that could impact the firm's forward-looking guidance and long-term profitability.

### SEC Filing Highlights
UnitedHealth Group’s profitability, driven by risk-based products comprising nearly 80% of revenue, remains highly sensitive to the accuracy of medical cost predictions and the impact of inflation or utilization spikes. The company faces significant cybersecurity and data privacy risks, highlighted by the 2024 Change Healthcare breach, which underscores vulnerabilities to sophisticated threats and third-party dependencies. Additionally, operational integrity relies on robust technology systems and data accuracy, with rapid AI evolution and regulatory changes posing ongoing compliance and integration challenges.

### Risk Factors

*   **Inaccurate Cost Estimation and Management:** Failure to accurately price or manage medical costs for risk-based products—which constitute nearly 80% of total revenues—could materially adversely affect financial results due to factors like medical inflation, utilization spikes, and regulatory changes.
*   **Cybersecurity, Data Integrity, and AI Risks:** Exposure to cyberattacks, data breaches, and system failures poses significant risks of revenue loss, liability, and operational disruption, while the rapid expansion of healthcare data and AI integration requires substantial resources to maintain security and technological competitiveness.
*   **Provider Relationships and Value-Based Care Performance:** Inability to maintain satisfactory relationships with healthcare providers or deliver higher-quality outcomes at lower costs within Optum Health’s value-based care models could negatively impact financial performance and competitive standing.

## Audited (Exec Summary + Outlook)

### Executive Summary
UnitedHealth Group is a dominant healthcare conglomerate generating $450.5 billion in annual revenue, leveraging its scale to produce $14.1 billion in net income despite a modest 3.14% net profit margin. The stock is notable for its significant valuation compression, with the forward P/E of 16.74 suggesting anticipated earnings growth that contrasts with a trailing P/E of 24.35. The single most important near-term variable shaping the investment outcome is the company’s ability to accurately predict and manage medical costs within its risk-based products, which comprise nearly 80% of revenue.

### Outlook
The directional outlook for UnitedHealth Group is cautiously constructive, anchored by its massive scale and consistent capital return program, yet tempered by persistent operational and regulatory headwinds. Key variables to monitor include the stability of medical cost trends, the efficacy of cybersecurity defenses following recent breaches, and the company’s ability to navigate the evolving AI landscape without compromising data integrity. The thesis would be strengthened by evidence of stable utilization rates and successful integration of value-based care models, whereas a deterioration in provider relationships or a surge in unanticipated medical inflation would significantly weaken the investment case.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically evaluate every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the **Executive Summary** and **Outlook** sections.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "$450.5 billion in annual revenue"
LABEL: SUPPORTED
REASON: Source data lists revenue as $450,525,986,816, which rounds to $450.5 billion, and the pre-written Financial Health section states "annual revenue of $450.5 billion."

---

CLAIM: "$14.1 billion in net income"
LABEL: SUPPORTED
REASON: Source data lists net_income as $14,122,000,384, which rounds to $14.1 billion, consistent with the pre-written Financial Health section.

---

CLAIM: "3.14% net profit margin"
LABEL: SUPPORTED
REASON: Source data explicitly states profit_margin_pct as 3.14, and the pre-written Financial Health section confirms "net profit margin of 3.14%."

---

CLAIM: "forward P/E of 16.74"
LABEL: SUPPORTED
REASON: Source data lists forward_pe as 16.743778, which rounds to 16.74, consistent with the pre-written Financial Health section's "forward P/E of 16.74."

---

CLAIM: "trailing P/E of 24.35"
LABEL: SUPPORTED
REASON: Source data lists pe_ratio as 24.34598, which rounds to 24.35, consistent with the pre-written Financial Health section's "trailing P/E ratio of 24.35."

---

CLAIM: "nearly 80% of revenue"
LABEL: SUPPORTED
REASON: Both the RAG SEC Highlights and Risk Factors sections explicitly state that risk-based products "constitute nearly 80% of total consolidated revenues," and this figure is carried through the pre-written sections.

---

**OUTLOOK**

The Outlook section contains no additional specific quantitative figures, price targets, thresholds, ratios, metrics, or percentages beyond those already evaluated above. All claims in the Outlook are qualitative or directional in nature (e.g., "cautiously constructive," "massive scale," "consistent capital return program," "recent breaches," "evolving AI landscape," "stable utilization rates," "value-based care models," "provider relationships," "medical inflation"). These are not quantitative or forward-looking numerical claims subject to the audit criteria, and therefore no additional entries are required.

---

**SUMMARY TABLE**

| Claim | Label |
|---|---|
| $450.5 billion in annual revenue | SUPPORTED |
| $14.1 billion in net income | SUPPORTED |
| 3.14% net profit margin | SUPPORTED |
| Forward P/E of 16.74 | SUPPORTED |
| Trailing P/E of 24.35 | SUPPORTED |
| Nearly 80% of revenue (risk-based products) | SUPPORTED |

All six auditable quantitative claims in the Executive Summary and Outlook are **SUPPORTED** by the source data. No quantitative claims were found to be UNSUPPORTED or INFERENCE.
